ANGPTL4 and neoplasm: In situ ANGPTL4 expression in tumor cells of primary tumors is associated with poor prognosis and metastatic relapse in patients with localized breast [14, 24–27], gastric [15, 28], head and neck [29], colon [30], and hepatocellular carcinoma [31–33].